Oxford Nanopore has continued its funding streak with another $108m, bringing this year's haul to more than $208m and its overall total to around $800m.

Oxford Nanopore, a UK-based genetic sequencing technology spinout of University of Oxford, obtained £84.4m ($108m) in funding today from a consortium including pension fund manager RPMI Railpen. The deal was backed by a group of new and existing investors including diversified holding group International Holdings Company. Founded in 2005, Oxford Nanopore produces DNA and RNA…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.